ROBERT J. PEREZ - 22 May 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Sung Lee, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
22 May 2023
Net transactions value
$0
Form type
4
Filing time
24 May 2023, 14:44:55 UTC
Previous filing
08 Mar 2023
Next filing
02 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +6,027 +62% $0.000000 15,806 22 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +12,054 $0.000000 12,054 22 May 2023 Common Stock 12,054 $25.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.